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1. Introduction
 
   Alzheimer’s disease (AD) is a progressive, irreversible 
neurological disorder that occurs gradually and results in 
memory loss, unusual behavior, personality changes, and 
loss of the ability to thinking[1]. It is estimated to affect 15 
million people worldwide. AD is the cause of dementia 
in the elderly. AD is a progressive neurological disorder 
with duration of around 8.5 years between onset of clinical 
symptoms and death[2].
   AD starts with loss of short term memory, forgetting 
names and addresses, as this condition progresses, the 
change become more marked and even individuals forget 
the home way. Unfortunately, AD has not any cure but can 
be prevented from progressing. Seventy percent of causes 
for AD is genetic and 21% is environmental. Most cases of 
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Alzheimer’s, approximately 95%, are the late-onset form, 
which develops after age 60[3].
   The causes for disease progress in American and European 
countries are feeding, and reduced physical and mental 
activity. Unfortunately, the number of people with AD is 
expected to triple in the next 50 years. The average cost 
per patient is estimated 150 thousand dollars that expected 
future increases to 450 thousand dollars[3]. 
   Brain areas associated with cognitive functions, particularly 
the neocortex and hippocampus, are the regions that mostly 
affected by the pathology which is characteristic of AD[4]. 
   The main cure for AD is pharmacological treatment. Better 
understanding of the disease process and designed clinical 
trial are step forward and have improved related treatments 
for cognitive and noncognitive symptoms. Pharmacological 
treatment strategies in AD include three categories of 
drug: 1) their mechanism is based on disease-modifying 
therapies such as vitamin E; 2) their mechanism is based on 
compensation of neurotransmitter such as a cholinesterase 
inhibitor; 3) psychotherapy factors that are prescribed for 
symptoms of conduct disorder[5].
   At present, the most accepted AD treatment strategy 
is cholinesterase inhibitors that can inactivate the 
acetylcholinesterase (AChE) enzyme in order to increase 
acetylcholine levels in the brain. Acetylcholinesterase 
inhibitors include rivastigmine, tacrine, donepezil, and 
galantamine whereas methyl-D-aspartate receptor antagonist 
(memantine) has recently been prescribed. However, there is 
no cure for AD, except to relieve symptoms of the disease[6].  
   These results lead us to factor that increase levels of the 
acetylcholine in the brain.
   In this study, medicinal plants that have shown the early 
promising signs of clinical efficacy in the treatment of AD 
have been investigated. One common feature of these plants 
is their ability to exert neuroprotective effects through 
inhibition of AChE or inhibition of oxidative stress.
   Although recently several synthetic drugs have been 
introduced to treat learning and memory disorder, but their 
therapeutic effects is low and most of them have undesirable 
side effects. Today we can see the increasing tendency of 
people towards traditional medicine[7]. 
   Although the mechanism of anti-dementia effect of 
most herbal extracts and their compounds is not yet fully 
understood, one or more of medicinal plants and their 
constituents that are discussed in this study act through 
inhibition of AChE and activation of the synthesis of 
acetylcholine. While cholinesterase inhibitors which have 
been recently introduced such as tacrine and donepezil 
reduced the number of AD patients and relieve their 
symptoms, most of Alzheimer’s patients have not still 
benefited considerably from major financial investments in 
research and development programs[8]. 
   Recent studies have shown promising results of the 
effectiveness of herbal medicines for the treatment of 
various diseases include memory problems[9-13], stroke 
[14-19], gastrointestinal problems[20], and many others 
disease. Although these effects can related to their specific 
compounds, but most of them have been related to their 
antioxidant properties.
2. Pathogenesis of AD
   Impairment of learning and memory, the most 
characteristic manifestation of dementia can be chemically 
induced in experimental animals by scopolamine. 
Scopolamine is a known cholinergic antagonist that involved 
in the transmission of acetylcholine in the central nervous 
system[21]. Cholinergic transmission is mainly terminated 
by acetylcholine hydrolysis by the enzyme AChE, which is 
responsible for degradation of acetylcholine to acetate and 
choline in the synaptic cleft[22]. 
   Scopolamine-induced amnesia in animal models is widely 
used to screen for compounds with potential therapeutic 
value in treatment of dementia[23]. 
   Decrease of acetylcholinetransferase enzyme activity 
and loss of cholinergic neurons were observed in the basal 
part of the frontal brain of AD patient that associated with 
cognitive impairment[24]. 
   Lesion patterns of the nucleus basalis of Meynert (NBM) 
is used to study the role of cortical cholinergic system in 
awareness and understanding, also to indicate cognitive 
deficits that caused in AD[25]. Destruction of NBM in animal 
models showed reduction in cholinergic markers include 
levels of acetylcholine, acetylcholine release and turnover, 
uptake of acetylcholine, AChE activity and number of 
cholinergic muscarinic receptors in the frontal cortex[26]. 
Because the cholinergic ramifications are sent from Maynert 
nuclei into the cortex and septal area, electrical destruction 
of NBM causes death of the cholinergic cells in this nucleus 
and reduces the amount of acetylcholine in the cortex[27].
   Hippocampus plays a critical role in learning and memory, 
which is a complex biological process including the 
acquisition, consolidation and retrieval of information[28]. 
Neurogenesis in the hippocampus, defined as the generation 
of new nerve cells, is involved in memory formation. 
Increased neurogenesis is improved spatial memory while 
impaired neurogenesis indicates poor cognitive function[29]. 
Important neuropathological features of AD include 
deposition of amyloid plaques in brain tissue and meningeal 
blood vessels as well as presence of neurofibrillary tangles 
in the hippocampus and the cerebral cortex of the brain[30].
Recent studies have demonstrated that AD is associated 
with inflammatory processes. Reactive oxidative species 
can damage cellular components and function as a second 
messenger in the inflammation. Utilization of antioxidants 
may be useful in prevention and treatment of AD[31].
   One factor that plays an important role in the pathogenesis 
of AD is oxidative stress that is an imbalance between free 
radicals and antioxidant systems. Oxygen free radicals 
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can attack proteins, nucleic acids and lipid membranes, 
therefore disrupt cellular function and integrity. Brain tissue 
contains large amounts of polyunsaturated fatty acids which 
are particularly vulnerable to free radical attack. Lipid 
peroxidation is thought to be destructive form of oxidative 
degradation that damage cell membrane and produces a 
number of secondary products, both of the loop and splitting 
forms of oxygenated fatty acids have neurotoxic effects[32]. 
Increase in the levels of malondialdehyde (MDA), one of 
the reactive oxidative species, has been recognized as an 
important lipid peroxidation indicator[33].
   Extensive researches on different plants are underway 
worldwide. Plant extracts have rather more therapeutic 
benefits and fewer side effects and are more economical. 
Plant extracts may provide a source of new compounds 
including many drugs that are derived from plant sources.
3. Medicinal plants used for the treatment of AD
3.1. Hypericum perforatum
   Hypericum is herbaceous perennial plant with a height of 
30-80 cm. It has glabrous and somewhat creepy stem. This 
plant’s leaves are spoon-shaped and sessile, with numerous 
cavities of essential oil and its species name (perforatum) is 
derived from this feature. Flowering branches and leaves of 
this plant contain compounds such as essential oils, tannins, 
hayperciyn, hayperpyron, choline and flavonoids. Clinical 
effects of Hypericum include amelioration of neurological 
diseases, antidepressant, anti-anxiety, anti-inflammatory, 
wound healing and analgesic effects[34].
   Hypericum extract containing flavonoids such as quercetin 
and quercitrin which shows free radical scavenging activity, 
antioxidant activity of quercetinis also were shown by the 
inhibition of lipid peroxidation[35].  
   In a study learning and memory impairment, associated 
with change in brain oxidative stress status caused in rat 
by acute injection of scopolamine (1.4 mg/kg). Scopolamine 
injection increased MDA levels and glutathione peroxidase 
activity of the brain and also reduced brain glutathione 
levels. These are responsible for increase in brain oxidative 
stress. Increase in the glutathione level of brain can directly 
decrease reactive oxidative species level. Pretreatment 
with Hypericum ( 4, 8 and 12 mg), 30 min before injection 
of scopolamine, showed antioxidant activity through their 
effects on brain MDA and glutathione level and also on 
glutathione peroxidaze activity[33]. 
   Repeated administration of Hypericum and its active 
ingredient, hyperforin improved passive avoidance 
memory in mice via shuttle box[36]. Hypericum extract as an 
antioxidant agent can be a new type of antidepressant with 
memory-enhancing properties[33]. 
3.2. Lepidium meyenii
   Maca (Lepidium meyenii) grows at altitudes of 3 500 to 4 500 
meters in the Andes of Peru. Maca is one of the few plants 
that have succeeded to survive in the difficult condition of 
high Andes altitude, burning sun, hot days, cold nights and 
dry winds[37]. 
   In a study effect of different doses of aqueous and 
hydroalcoholic extract of maca on learning and memory 
deficits induced by scopolamine (1 mg/kg) in mice 
has been investigated for 35 d. Maca improved spatial 
learning and memory impairments and ameliorate passive 
avoidance learning and memory deficits. The results 
indicated that scopolamine increase AChE activity in the 
mice brain up to 1.5-fold. Maca extract reduced brain 
AChE activity by 45% compared to the group that received 
only scopolamine[38]. 
   Black maca increased step-down latency in avoidance 
test when compared to ovariectomized control mice also 
Black maca decreased brain MDA and AChE levels in 
ovariectomized mice. Black maca improved experimental 
memory impairment induced by ovariectomy, by its 
antioxidant and AChE inhibitory activities[39].
   Mice treated with ethanol took more time to find the 
hidden platform than control during escape acquisition 
trials in Morris water maze test; by the way, black maca 
reversed the effect of ethanol. Black maca ameliorated the 
deleterious effect of ethanol during the probe trial[40]. 
3.3. Prunella vulgaris (P. vulgaris)
   P. vulgaris is widely distributed in Korea, Japan, 
China and Europe. It is a traditional Chinese and Korean 
medicine that has been used to treat inflammation, eye 
pain, headache and dizziness[41]. 
   Previous studies have demonstrated that P. vulgaris 
contains several active compounds such as oleic acid, 
ursolic acid, butyric acid, flavonoids and rosmarinic 
acid[42]. In addition, this plant has anti-allergy, anti-
inflammatory, antioxidant, antimicrobial and antiviral 
activity[43].
   P. vulgaris extract (25 and 50 mg) reduced latency in 
rats that received scopolamine in the shuttle box test. In 
addition, the extract of P. vulgaris ameliorated scopolamine 
induced impairments in the Y-maze test. This plant’s 
beneficial effects are the result of imitation of acetylcholine 
effect. P. vulgaris does not inhibit AChE activity in vivo 
or ex vivo conditions and memory-enhancing effects of 
P. vulgaris do not work through inhibition of AChE, this 
achieved by an indirect effect on cholinergic signaling. 
P. vulgaris express its beneficial effects on memory and 
learning via increase of cholinergic neurotransmitters and 
methyl-D-aspartate receptor signaling[41]. Flavonoids from 
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P. vulgaris exhibit significant antioxidant activities[44].
3.4. Cyperus rotundus (C. rotundus)
   Sedge or C. rotundus belongs to the family Cyperaceae. 
The rhizome of Cyperus is rich in essential oils that contain 
pinene, a little cineole, terpenes, and a new alcohol called 
isociprol. Several chemical components have been isolated 
from ethanol extract of C. rotundus rhizome and some of 
these chemicals possess anti-AChE activity[45].
   Studies have shown that the severity of dementia in AD 
depends on the reduction of neurons in the Meynert nucleus 
that accompanied by the significant decrease in the amount 
of acetylcholine transferase enzymes in the cortex and 
amygdala and causes impaired learning[46].
   NBM located in the frontal base of brain and majority 
of its cells are cholinergic[47]. Because the cholinergic 
ramifications is sent from Meynert nucleus to the cortex and 
septal, electrical lesion of NBM causes cholinergic cells death 
in the nucleus and reduces the amount of acetylcholine in 
the cortex[27]. 
   In a study, rats with damaged NBM received two doses of C. 
rotundus extracts (100 and 200 mg/kg). C. rotundus extracts 
with anti-AChE effect improved spatial learning and 
memory as well as passive avoidance learning[11].
3.5. Zizyphus jujube
   The immature jujube fruit is green in color, but as ripe, 
it becomes red and begins to wrinkle. The jujube fruit has 
long and elongated nucleus and is fully ripe in autumn. It is 
edible, sweet tasting and has medicinal properties. Jujube 
has soothing and anti-grouch properties, and has been used 
in traditional Korean and chinese medicine as a drug that 
reduces anxiety and strengthens the stomach, spleen and 
gastrointestinal system[48]. 
   Terpenoid, flavonoid and alkaloid compounds have been 
isolated from the jujube fruit, a phenyl glycosides compound 
has also been obtained from jujube fruit[49].
   Studies have shown that this herb contains compounds 
that exerted inhibitory activity against histamine release and 
activity of AChE and cyclooxygenase I and II. Furthermore, 
this herb has cytotoxic effect and activate biological 
compatibility. Jujube seeds contain large amounts of 
mucilage, malic acid, citric acid, sugar, protein, organic 
minerals and vitamin C[49-51].  
   Eight different types of flavonoids have been extracted 
from the jujube fruit and medicinal properties of jujube are 
attributed to the antioxidant properties of these compounds. 
Among the 50 examined plants, jujube extract showed the 
highest effect on the activation of acetylcholine transferase 
(34.1%) in the in vitro, a known compound that causes this 
effect is the cis-9-octadecenamide (oleamide)[52].
   The increase in acetylcholine level in the cholinergic 
terminals may contribute to improve Alzheimer’s symptoms 
and motor deficit[13]. 
   A treatment strategy for AD is compensation of normal 
concentration of acetylcholine in the synaptic cleft to 
improve neuronal transmission in the brain cholinergic 
terminals. Acetylcholine transferase activator increase 
acetylcholine level in order to improve mild to moderate 
cognitive function of AD[53]. 
   Jujube extract has restorative effects on learning and 
memory, motor coordination and behavioral disorders that 
caused by the Meynert nucleus lesion at the base of the 
rat brain’s frontal lobe. This effect may be due to jujube 
extract effect on the activation of acetylcholine transferase. 
It can reduce the high price for AD treatment, and can be 
appropriate complement for synthetic and chemical drugs 
associated with high adverse effects[9].
3.6. Lavandula officinalis
   Lavandula officinalis, known as lavender, has been 
traditionally considered. This plant has wide distribution 
and its flowers and essential oil is used in cosmetics 
and perfumes industry. Lavender is a plant of the genus 
Lavandula, its leaves looks like thyme leave but longer and 
thinner and has white flower[54]. 
   So far, 48 species have been identified from this genus 
that grow in various parts of southern Europe and the 
Mediterranean countries, especially in southern Italy, 
Yugoslavia, Greece, Southern France and Northern Africa. 
This species is not a wild flower in Iran but it has recently 
been cultivated in some area. Its flowers are purple and 
usually its flowers and flower-stalks are used. Lavender 
has a very pleasant smell and a bitter taste. It is used in the 
perfume and cosmetics industries for its pleasant smell. 
Lavender essential oil is extracted via steam distillation 
from the flowers and flower-stalks. Lavender essential oil is 
yellow or greenish yellow liquid with a pleasant aroma. Until 
now, few studies have been conducted on the phytochemical 
characteristics of this plant species[54].
   Many compounds have been detected in lavender extract, 
the most important of them include: geraniol, linalool, 
linalyl acetate, cineol, borneol, aflapin, camphor, butyric 
acid, valerianic acid, ursolic acid, and luteolin flavonoids, 
this compound may increase plant effects on central nervous 
system area, causing calming and soothing effects through 
GABA receptor[55].
   Treatment with lavender essential oil significantly 
decreased neurologic deficit, stroke volume, the level 
of MDA, carbonyl and reactive oxygen species in rats 
subjected to ischemia and reperfusion and showed strong 
neuroprotective effect[56].
   It is proved that the high activity of AChE enzyme and thus 
reduced amount of acetylcholine and synaptic transmission 
may contribute to the loss of spatial memory and cause 
AD. Inhibitory effects of different concentration of lavender 
extract on the AChE enzyme have been proved through 
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various tests on cell lines[57].
   It has been reported that free radicals cause peroxidation 
of phospholipids, DNA damage and protein denaturation. The 
hippocampus is the key brain area for spatial learning and 
memory. Long term potentiation is one of the most important 
cellular mechanisms that underlie learning and memory. It 
has been shown that increased consumption of antioxidants 
improves spatial learning and long term potentiation induction 
in mice with AD[58].
   In general, free radical production associated with several 
cellular processes such as cellular metabolism, mitochondrial 
respiration, cyclooxygenase and lipooxygenase activity, 
which may have been increased in brain. The amount of 
free radicals production in different part of the brain may 
be related to oxygen consumption on that area[59]. Since 
hippocampus that its oxygen consumption is higher, is more 
sensitive than other region. Protective effect of antioxidants 
may be due to their ability to give hydrogenation, or free 
radical scavenging strength[60].
   Ethanol extract of lavender improves spatial learning and 
memory, motor coordination and passive avoidance learning, 
these neuroprotective effects may be due to its antioxidant 
properties[10]. 
3.7. Ginkgo biloba (G. biloba)
   G. biloba, the oldest tree on the earth, is native to China and 
now cultivated in Europe and America. G. biloba extract treat 
insufficiency of blood circulation problems, especially in 
the brain that causes of memory loss, loss of consciousness, 
headaches, and depression in the elderly[61]. This extract 
is reported to contain about 24% flavonoids and 6% terpene 
lactones. There is reliable evidence that standardized ginkgo 
extract shows several molecular and cellular neuroprotective 
mechanisms, including the attenuation of apoptosis, the 
inhibition of membrane lipid peroxidation, anti-inflammatory 
effects and the direct inhibition of amyloid-b aggregation. 
There are extensive clinical investigations regarding its 
potential role in cognitive disorders[61].
   Chronic treatment of G. biloba on learning and memory in 
mice showed that G. biloba improved acquisition, storage, 
and retrieval of a two-response sequence for food reward[62]. 
The antioxidant and free-radical scavenging properties of G. 
biloba extract are primarily attributed to the flavonoid fraction. 
G. biloba affects cognitive function in an animal model of 
AD without altering the histopathological consequences of 
overexpression of β amyloid precursor protein[63].
   G. biloba extract significantly inhibit the AChE activity in 
the brain. The inhibition of AChE activity can be correlated 
with improvement observed in scopolamine-induced deficits 
in passive avoidance by G. biloba extract. The decrease in 
AChE activity indicates an increase in the basal level of 
acetylcholine[64]. 
3.8. Salvia officinalis (S. officinalis)
   S. officinalis has a very old reputation for improving 
memory. It is singularly good for the head and brain[65]. The 
potential pharmacological effects of the herb, which may be 
relevant to AD include anti-inflammatory and antioxidant 
properties as well as weak AChE inhibitory effect. The leaves 
of S. officinalis L. (sage) are well known for their antioxidative 
properties[66]. Rosmarinic acid (the main active ingredient 
of S. officinalis) reduced a number of deleterious events 
induced by Aβ include reactive oxygen species formation, 
lipid peroxidation, DNA fragmentation, caspase-3 activation 
and tau protein hyperphosphorylation[67]. S. officinalis 
have a long history of use as memory enhancing agents 
coupled with cholinergic properties that may be relevant to 
amelioration of the cognitive deficits associated with AD[68]. 
Based on clinical evidence S. officinalis may help to prevent 
or alleviate symptoms of AD. In a randomized double-blind 
clinical study, patients with mild-to-moderate AD received 
S. officinalis extract. The result showed that S. officinalis had 
statistically significant effectiveness in the cognition after 
16 weeks of treatment[69]. One small pilot trial showed that 
oral administration of S. officinalis essential oil to 11 patients 
showing mild-to moderate symptoms of AD significantly 
improved cognitive function. 
3.9. Melissa officinalis (M. officinalis)
   M. officinalis (lemon balm) is a cultivated perennial lemon 
scented herb. Records concerning its use date back over 2000 
years with entries in the Historia Plantarum. In traditional 
medicine M. officinalis L. (Lamiaceae) has been used as 
a remedy for over 2000 years, and has been acclaimed 
for promoting long life and for restoring memory[65]. The 
leaves of this plant contain monoterpenes (e.g. citral) with 
weak anti-AChE activity, and phenol carboxylic acids- 
including rosmarinic acid, which shows antioxidative, anti-
amyloidogenic and antiapoptotic effects. M. officinalis 
essential oil, given in canary wine, every morning will renew 
youth, strengthen the brain. Patients with mild to moderate 
AD receiving M. officinalis extract experienced significant 
benefits in cognition after 16 weeks of treatment[70]. M. 
officinalis has central nervous system acetylcholine receptor 
activity and modulates mood and cognitive performance 
following acute administration[71,72]. 
3.10. Ginseng
   For thousands of years, ginseng root, especially the 
main root, has been used as an East Asian medicinal 
herb for treatment of various diseases[73]. Ginseng grows 
in Northeastern Asia. In traditional Chinese and Korean 
medicine, ginseng root is used for boosting energy. It is 
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believed to be a powerful adaptogenic aphrodisiac that can 
be applied for patients with low energy, weak immune system 
and sexual dysfunction. Use of ginseng extract may enhance 
cognitive and psychomotor functions and can benefit AD 
by improving brain cholinergic function, reducing the 
level of Aβ, and repairing neuronal networks damage[74-76]. 
Treatment with red ginseng significantly ameliorated place-
navigation deficits in young and aged rats with hippocampal 
lesions in the place learning task[77]. Oral administration 
of ginseng powder prevented the ischemia-induced 
decrease in response latency, as determined by the passive 
avoidance test, and rescued a significant number of ischemic 
hippocampal CA1 pyramidal neurons in a dose-dependent 
manner[78]. One of the main bioactive components in 
ginseng is ginsenoside that play an important role in central 
nervous system[79,80]. It has been proved to be effective in 
the attenuation of learning deficits due to brain damage and 
aging in humans and animals[81].
3.11. Morinda citrifolia (M. citrifolia)
   M. citrifolia, commonly known as noni, is widely used 
as food in tropical regions of the Indonesian to Hawaii 
Island. This species is a small tree with a straight trunk and 
cultivated in different parts of India[82].
   As a popular herb, M. citrifolia juice is used as an 
alternative medicine for a variety of diseases such as arthritis, 
diabetes, high blood pressure, menstrual problems, heart 
disease, cancer, ulcers, depression, and atherosclerosis[83].
   M. citrifolia fruit and extract have analgesic, anti-
inflammatory and antioxidant properties[84]. Ethyl acetate 
extract of M. citrifolia prevented memory deficit and 
oxidative stress induced by amyloid beta peptide in mice[82]. 
Treatment with chloroform, ethyl acetate and butanol extracts 
of M. citrifolia in a dose-dependent manner reduced AChE 
enzyme activity in the brain of scopolamine-treated mice[84].
   In addition, scopolamine-induced amnesia is associated 
with decreased cerebral blood flow and increased oxidative 
stress and AChE activity in rat brain, and treatment with the 
M. citrifolia extract improved scopolamine induced memory 
impairment in the shuttle box test[84].
3.12. Lycopodium serratum
   Lycopodium is a genus of clubmosses, also known 
as ground pines or creeping cedar, in the family 
Lycopodiaceae, a family of fern-allies. The leaves contain 
a single, unbranched vascular strand and are microphylls 
by definition[85]. The genus Lycopodium (Lycopodiaceae), 
which produces a potential therapeutic agent, huperzine 
A, for the treatment of AD, has been extensively studied 
in recent years[85]. Huperzine A is an alkaloid extracted 
from Lycopodium serratum and has been used for 
centuries to treat fever, inflammation, blood disorders and 
schizophrenia[86]. It is a highly selective, reversible, and 
potent AChE inhibitor, and potency of AChE inhibition is 
similar or superior to that of physostigmine, galanthamine, 
donepezil and tacrine[87]. The huperzine A is a strong 
candidate for treatment of AD. Other potentially beneficial 
effects, as far as AD is concerned, include protection 
against Aβ-induced oxidative injury and neuronal 
apoptosis, regulation of nerve growth factor and reduction 
in glutamate-induced toxicity[88]. Huperzine A caused a 
significant increase in ACh levels in rat brain[88]. Huperzine 
A has several protective effects such as regulating amyloid 
precursor protein metabolism, protecting against Aβ 
mediated oxidative stress, apoptosis and mitochondrial 
dysfunction, as well as anti-inflammation[89].
3.13. Polygala tenuifolia (P. tenuifolia)
   P. tenuifolia is one of the 50 fundamental herbs used in 
traditional Chinese medicine. The root of P. tenuifolia used 
as an expectorant, a tonic, and a tranquillizer for treating and 
preventing dementia[90,91]. 
   Tenuigenin (which is a compound extracted from the 
Chinese herb P. tenuifolia), exhibits the property of soothing 
the mind and is indicated for insomnia, mental confusion and 
disorientation in Chinese medicine. Studies have suggested 
that tenuigenin can inhibit the secretion of Aβ from cultured 
cells and thus ameliorate the reduction in cholinergic 
function on rat models induced by Aβ[92]. Treatment 
with P. tenuifolia in NBM lesioned rats both the impaired 
rats’ behavioral expression and memory test results had 
improved[93]. 
   P. tenuifolia showed the ameliorative effect on 
scopolamine-induced decrease of the retention of passive 
avoidance by enhancing the central cholinergic system[94]. 
The water extract of P. tenuifolia up-regulated the choline 
acetyltransferase activity in vitro[95]. Gycoside-rich fraction 
from P. tenuifolia has improvement effect on the retrieval 
process in spatial cognition using eight-arm radial maze 
assay systems[96].
3.14. Celastrus paniculatus (C. paniculatus)
   C. paniculatus (Celastraceae) is an Indian medicinal plant 
which has been used in the traditional Ayurvedic system of 
medicine for years. C. paniculatus may be employed as a 
stimulant nervine tonic, rejuvenant, sedative, tranquilizer 
and diuretic[97]. 
   Plant seed and seed oil are reported to be highly 
beneficial in stimulating intellect and sharpening the 
memory. A study suggested that the oral administration of 
the seed oil decreased levels of noradrenaline, dopamine 
and 5-hydroxytryptamine in rat brain and thus improved 
learning and memory processes, in addition, the oil was not 
neurotoxic[98]. 
   Administration of the seed oil to rats also reversed a 
scopolamine-induced task deficit. An aqueous seed 
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extract showed an antioxidant effect in the central nervous 
system, which may also explain the reputed benefits on 
memory, since this extract enhanced cognition in vivo[98]. 
The aqueous extract of C. paniculatus at a dose of 200 mg/kg 
showed improvement in learning and memory tasks in both 
the shuttle-box and step through paradigms[99]. There is a 
marginal increase in activity of AChE in the hippocampus 
when the animal is treated with 200 mg/kg body weight of 
Celastrus seed oil[100].
4. Conclusions
   No treatment is available to slow or stop AD. The U.S. 
Food and Drug Administration has approved five drugs that 
temporarily improve symptoms. The effectiveness of these 
drugs varies across the population. None of the treatments 
available today alters the underlying course of this terminal 
disease[2].  
   Herbs show promise in AD treatment because of their 
cognitive benefits and more importantly, their mechanisms of 
action with respect to the fundamental pathophysiology of the 
disease.
   In summary, preliminary clinical evidence demonstrated 
that some herbal medicines can ameliorate learning and 
memory in patients with mild-to-moderate AD. Potential 
beneficial actions exerted by the active components of 
these herbs are not limited to the inhibition of AChE and 
include the modification of Aβ processing, protection 
against apoptosis and oxidative stress, and anti-
inflammatory effects. 
   The use of medicinal plants in the treatment of AD should 
be compared with the pharmacological treatment currently in 
use. These studies should include fundamental identification 
in order to confirm the clinical trial.
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Comments 
Background
   
    AD is a progressive, irreversible neurological disorder 
that occurs gradually and results in memory loss, unusual 
behavior, personality changes, and loss of the ability to 
thinking. This review article focuses on medicinal plants 
used in the treatment of learning and memory impairments. 
The topic is interesting and can be further referenced.
Research frontiers
   This is an interesting review article on flora medical 
science and can be useful in further ethnopharmacology 
study. 
Related reports
   There are some relating reports as cited and quoted in this 
review article. 
Innovations and breakthroughs
   In this present work, authors made an attempt to show 
interesting summative review of the available information of 




   This work can be further applied in pharmaceutical 
research and it can also be further referenced in tropical 
biomedicine. 
Peer review
   This is an interesting review article on the tropical 
available plants that can be used in the treatment of 
learning and memory impairments (such as Alzheimer). 
The article can fulfill the present scattering knowledge in 
medicinal plants. The topic is interesting and can be further 
referenced. The review data can be the source for used in 
further study in tropical ethnopharmacology study. 
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